Resultaten

Artikel
Dit item is dichtgeklapt
Dit item is opengeklapt

Titel: Gluten: a two-edged sword. The molecular basis of Celiac Disease. In: Springer seminars in immunopathology.
Auteur(s): Koning F, Gilissen L, Wijmenga C
Start- en eindpagina: 217 - 232

Titel: Large-scale characterization of natural ligands explains the unique gluten-binding properties of HLA-DQ2.
Auteur(s): Stepniak D, Wiesner M, de Ru AH, Moustakas AK, Drijfhout JW, Papadopoulos GK, van Veelen PA, Koning F.
Start- en eindpagina: 0 - 0

Titel: ATG16L1 and IL23R Are Associated With Inflammatory Bowel Diseases but Not With Celiac Disease in The Netherlands.
Auteur(s): Weersma RK, Zhernakova A, Nolte IM, Lefebvre C, Rioux JD, Mulder F, van Dullemen HM, Kleibeuker JH, Wijmenga C, Dijkstra G
Start- en eindpagina: 0 - 0

Titel: Associations with tight junction genes PARD3 and MAGI2 in Dutch patients point to a common barrier defect for celiac disease and ulcerative colitis
Auteur(s): Wapenaar MC, Monsuur A, van Bodegraven A, Weersma RK, Bevova M, Linskens R, Howdle P, Holmes G, Mulder CJJ, Dijkstra G, van Heel DA, Wijmenga C
Start- en eindpagina: 0 - 0

Titel: Association analysis of functional variants of the FcgRIIa and FcgRIIIa genes with type 1 diabetes, celiac disease and rheumatoid arthritis.
Auteur(s): Alizadeh BZ, Valdigem G, Coenen MJH, Zhernakova A, Franke B, Monsuur A, van Riel PLCM, Barrera P, Radstake TRDJ, Roep BO, Wijmenga C, Koeleman BPC
Start- en eindpagina: 2552 - 2559

Titel: A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21.
Auteur(s): van Heel DA, Franke L, Hunt KA, Gwilliam R, Zhernakova A, Inouye M, Wapenaar MC, Barnardo MC, Bethel G, Holmes GK, Feighery C, Jewell D, Kelleher D, Kumar P, Travis S, Walters JRF, Sanders DS,Howdle P, Swift J, Playford R, McClaren W, Mearin ML, Mulder CJ, McManus R, McGinnis R, Cardon L, Deloukas P, Wijmenga C
Start- en eindpagina: 827 - 829

Titel: The SPINK gene family and coeliac disease susceptibility.
Auteur(s): MC Wapenaar, Monsuur AJ, Poell J, van 't Slot R, Meijer JWR, Meijer GA, Mulder CJJ, Mearin ML, Wijmenga C
Start- en eindpagina: 349 - 357

Titel: Understanding the molecular basis of celiac disease: what genetic studies reveal
Auteur(s): Monsuur AJ, Wijmenga C
Start- en eindpagina: 578 - 591

Titel: Genetic variation in myosin IXB is associated with ulcerative colitis.
Auteur(s): van Bodegraven AA, Curley CR, Hunt KA, Monsuur AJ, Linskens RK, Onnie CM, Crusius BA, Annese V, Latiano A, Silverberg MS, Bitton A, Fisher SA, Steinhart AH, Forbes A, Sanderson J, Prescott NJ, Strachan DP, Playford RJ, Mathew CG, Daly MJ*, Rioux JD*, van Heel DA*, Wijmenga C*(
Start- en eindpagina: 1768 - 1774

Titel: Association analysis of MYO9B gene polymorphisms with inflammatory bowel disease in a Norwegian cohort.
Auteur(s): Amundsen SS, Vatn M and the IBSEN study group, Wijmenga C, Sollid LM, Lie BA
Start- en eindpagina: 249 - 252

Titel: The down-stream modulator of interferon-gamma, STAT1 is not genetically associated to the Dutch celiac disease population.
Auteur(s): Diosdado B, Monsuur AJ, Mearin ML, Mulder CJ, Wijmenga C
Start- en eindpagina: 1120 - 1124

Titel: Highly efficient gluten degradation with a novel prolyl endoprotease from Aspergillus niger.
Auteur(s): Stepniak D, Spaenij-Dekking L, Mitea C, Moester M, de Ru A, Baak-Pablo R, van Veelen P, Edens L, Koning F.
Start- en eindpagina: 621 - 629

Titel: Association analysis of MYO9B gene polymorphisms with celiac disease in a Swedish/Norwegian cohort.
Auteur(s): Amundsen SS, Monsuur AJ, Wapenaar MC, Lie BA, Ek J, Gudjónsdóttir AH, Ascher H, Wijmenga C, Sollid LM
Start- en eindpagina: 341 - 345

Titel: Association studies of MYO9B genetic variants in a British coeliac disease cohort
Auteur(s): Hunt KA, Monsuur A, Kumar PJ, Travis SPL, Walters JRF, Jewell DP, Playford RJ, Wijmenga C, van Heel DA
Start- en eindpagina: 969 - 972

Titel: Celiac Disease: sandwiched between innate and adaptive immunity.
Auteur(s): Stepniak D, Koning F.
Start- en eindpagina: 460 - 468

Titel: Genetic and functional analysis of pyroglutamyl-peptidase I in coeliac disease.
Auteur(s): Monsuur AJ, Stepniak D, Diosdado B, Wapenaar MC, Mearin ML, Koning F, Wijmenga C
Start- en eindpagina: 637 - 644

Titel: A functional candidate screen for coeliac disease genes.
Auteur(s): Curley CR, Monsuur AJ, Wapenaar MC, Rioux JD, Wijmenga C
Start- en eindpagina: 1215 - 1222

Titel: Myosin IXB variant increases the risk of celiac disease and points towards a primary intestinal barrier defect.
Auteur(s): Monsuur AJ, de Bakker PIW, Alizadeh BZ, Zhernakova A, Bevova MR, Strengman E, Franke L, van t' Slot R, van Belzen MJ, Lavrijsen ICM, Diosdado B, Daly MJ, Mulder CJJ, Mearin ML, Meijer JWR, Meijer GA, van Oort E, Wapenaar MC, Koeleman BPC, Wijmenga C
Start- en eindpagina: 1341 - 1344

Titel: Genetics in coeliac disease.
Auteur(s): van Heel DA, Hunt K, Greco L, Wijmenga C
Start- en eindpagina: 323 - 339

Titel: Coelionomics": towards understanding the molecular pathology of coeliac disease.
Auteur(s): Diosdado B, van Oort E, Wijmenga C
Start- en eindpagina: 685 - 695

Titel: A combined genetics and genomics approach to unravelling molecular pathways in coeliac disease.
Auteur(s): Wapenaar MC, Wijmenga C
Start- en eindpagina: 113 - 143

Titel: No genetic association of the human prolyl endopeptidase gene found in the Dutch celiac disease population.
Auteur(s): Diosdado B, Stepniak DT, Monsuur AJ, Franke L, Wapenaar MC, Mearin ML, Koning F, Wijmenga C
Start- en eindpagina: 495 - 500

Titel: The Interferon Gamma Gene in Celiac Disease: Expression Correlates with Tissue Damage but no Evidence for Genetic Risk.
Auteur(s): Wapenaar MC, van Belzen MJ, Fransen JH, Sarasqueta AF, Houwen RHJ, Meijer JWR, Mulder CJJ, Wijmenga C
Start- en eindpagina: 183 - 190

Titel: A microarray screen for novel candidate genes in Celiac Disease pathogenesis.
Auteur(s): Diosdado B, Wapenaar MC, Franke L, Duran KJ, Goerres MJ, Hadithi M, Crusius JBA, Meijer JWR, Duggan DJ, Mulder CJJ, Holstege FCP, Wijmenga C
Start- en eindpagina: 944 - 951

Titel: T cell recognition of HLA-DQ2-bound gluten peptides can be influenced by an N-terminal proline at p-1.
Auteur(s): Stepniak, LW Vader, Y Kooy, PA van Veelen, A Moustakas, NA Papandreou, E Eliopoulos, JW Drijfhout, GK Papadopoulos, and F Koning
Start- en eindpagina: 8 - 15

Titel: The HLA-DQ2 gene dose effect in Celiac Disease is directly related to the magnitude and breadth of gluten-specific T-cell responses.
Auteur(s): Vader W, Stepniak D, Kooy Y, Mearin ML, Thompson A, Spaenij L, Koning F.
Start- en eindpagina: 12390 - 12395

Titel: Molecular mechanisms of the adaptive, innate and regulatory immune responses in the intestinal mucosa of celiac disease patients.
Auteur(s): Monsuur AJ, de Bakker PIW, Alizadeh BZ, Zhernakova A, Bevova MR, Strengman E, Franke L, van t' Slot R, van Belzen MJ, Lavrijsen ICM, Diosdado B, Daly MJ, Mulder CJJ, Mearin ML, Meijer JWR, Meijer GA, van Oort E, Wapenaar MC, Koeleman BPC, Wijmenga C
Start- en eindpagina: 681 - 700

Titel: A genomics view on celiac disease points to enhanced neutrophil recruimtment and barrier impairment.
Auteur(s): Diosdado B, van Bakel H, Strengman E, Franke L, van Oort E, Mulder CJJ, Wijmenga C, Wapenaar MC
Start- en eindpagina: 574 - 581

Presentatie
Dit item is dichtgeklapt
Dit item is opengeklapt

Titel: A functional-genetics approach to unravel molecular pathways in celiac disease.

Proefschrift
Dit item is dichtgeklapt
Dit item is opengeklapt

Titel: Unraveling the molecular genetic aspects of intestinal inflammatory disorders.
Auteur(s): AJ Monsuur
Publicatiedatum: 03-07-2007

Titel: Celiac Disease
Auteur(s): D Stepniak
Publicatiedatum: 14-12-2006

Naar boven
Direct naar: InhoudDirect naar: NavigatieDirect naar: Onderkant website